Subscribe

News
Media
Conference
Publication
CME/CE
Partners
Resources
Contribute
Subscribe

Stacy Lindborg, PhD

Articles by Stacy Lindborg, PhD

IMUNON’s IMNN-101 Vaccine Shows Promising Results in Phase 1 Trial, Demonstrates Cross-Reactivity Against COVID Variants

BySophia Abene,Stacy Lindborg, PhD

March 7th 2025

Stacy Lindborg, PhD, highlights the vaccine’s immune response, safety, and global distribution potential.

Latest Updated Articles

Trending on Contagion Live

Dynavax and Vaxart Partner to Advance Oral COVID-19 Vaccine

Clesrovimab Lowers RSV Hospitalizations and Illness in Healthy Infants

FDA Clears Immuron’s IMM-529 For Clinical Testing in C difficile; Phase 2 Set to Begin in Australia

Using Doxycycline for Post-Exposure Prevention of Lyme Disease in Young Kids

Streamlining Care Models Key to Managing Skin and Soft Tissue Infections

© 2025 MJH Life Sciences^®

All rights reserved.